Back
Biohaven Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
50
BHVN
Biohaven
Last Price:
46.06
Seasonality Move:
26.66%
Sell
36
VNDA
Vanda Pharmaceuticals
Last Price:
4.84
Seasonality Move:
4.27%
Sell
50
Biohaven (BHVN)
is a Sell
Is Biohaven a Buy, Sell or Hold?
- The current Biohaven [BHVN] share price is $46.06. The Score for BHVN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BHVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $4.84. The Score for VNDA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- VNDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BHVN Stock Price Chart
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VNDA is experiencing slight buying pressure.
BHVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 45.55 | Sell |
| Chaikin Money Flow: | 221430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.21 - 51.31) | Sell |
| Bollinger Bands (100): | (37.89 - 50.17) | Buy |
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 45 | Sell |
| Chaikin Money Flow: | 49985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.78 - 5.22) | Sell |
| Bollinger Bands (100): | (4.65 - 5.59) | Sell |
BHVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.62 | Buy |
| 20-day SMA: | 47.69 | Sell |
| 50-day SMA: | 49.58 | Sell |
| 200-day SMA: | 43.63 | Buy |
| 8-day EMA: | 45.66 | Buy |
| 20-day EMA: | 47.02 | Sell |
| 50-day EMA: | 47.21 | Sell |
| 200-day EMA: | 42.31 | Buy |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.03 | Sell |
| 20-day SMA: | 5.07 | Sell |
| 50-day SMA: | 4.83 | Buy |
| 200-day SMA: | 5 | Sell |
| 8-day EMA: | 4.99 | Sell |
| 20-day EMA: | 4.99 | Sell |
| 50-day EMA: | 4.96 | Sell |
| 200-day EMA: | 5.04 | Sell |
Biohaven Earnings Growth & BHVN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.72 per share, and an increase next year of $2.70 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Biohaven Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vanda Pharmaceuticals Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||